Inclusion criteria
- Pregnant
Loading study record…
Loading study record…
In order to find how many women continue using alcohol during their pregnancies the plan is to anonymously test routine urine samples collected during pregnancies for ethylglucuronide (ETG), a metabolite of ethanol that is detectable in urine up to several days after alcohol consumptions. Altogether 600 samples are taken in the prenatal care units and the prenatal care units dedicated for the alcohol and drug abusing mothers both in the Helsinki and Lahti areas. Test results are used to estimate and compare the prevalence of severe maternal drinking in the different populations.
Locally preserved from ClinicalTrials.govOpen ClinicalTrials.govlast source update 2022-11-28
What this record can show
This locally preserved record separates the registered protocol from source-reported registry results. Neither is a treatment recommendation.
Registry facts
Linked local records
Local links use governed condition terms or exact source-reported intervention names. They are navigation candidates, not efficacy claims.
Interventions
No structured intervention was reported.
Eligibility
The study population for the ethylglucuronide (EtG) testing consists of the visitors in the HYKS, PHHYKY and the cities of Helsinki and Lahti prenatal care units, as well as the HYKS and PHHKYKY prenatal care units dedicated for the alcohol and drug abusing mothers (HAL- / HALSO-poliklinikka).
primary outcomes
Time frame: Day 1
The routine urine samples from the visitors are tested for ethyl glucuronide using dip sticks with 300ng cut off. Positve finds are confirmed in a laboratory.
secondary outcomes
Time frame: Day 1
The positive EtG urine samples and random negative urine samples from the visitors are tested for nicotine using dip sticks.
Time frame: Day 1
The positive EtG urine samples and random negative urine samples from the visitors are tested for cannabis using dip sticks.
Publications